165 related articles for article (PubMed ID: 35715395)
1. A global lipid map reveals host dependency factors conserved across SARS-CoV-2 variants.
Farley SE; Kyle JE; Leier HC; Bramer LM; Weinstein JB; Bates TA; Lee JY; Metz TO; Schultz C; Tafesse FG
Nat Commun; 2022 Jun; 13(1):3487. PubMed ID: 35715395
[TBL] [Abstract][Full Text] [Related]
2. A global lipid map reveals host dependency factors conserved across SARS-CoV-2 variants.
Farley SE; Kyle JE; Leier HC; Bramer LM; Weinstein J; Bates TA; Lee JY; Metz TO; Schultz C; Tafesse FG
bioRxiv; 2022 Feb; ():. PubMed ID: 35194611
[TBL] [Abstract][Full Text] [Related]
3. Lipid-based therapies against SARS-CoV-2 infection.
Alketbi EH; Hamdy R; El-Kabalawy A; Juric V; Pignitter M; A Mosa K; Almehdi AM; El-Keblawy AA; Soliman SSM
Rev Med Virol; 2021 Sep; 31(5):1-13. PubMed ID: 34546604
[TBL] [Abstract][Full Text] [Related]
4. A lipidomic view of SARS-CoV-2.
Ebrahimi KH; McCullagh JSO
Biosci Rep; 2021 Aug; 41(8):. PubMed ID: 34313294
[TBL] [Abstract][Full Text] [Related]
5. Equine Anti-SARS-CoV-2 Serum (ECIG) Binds to Mutated RBDs and N Proteins of Variants of Concern and Inhibits the Binding of RBDs to ACE-2 Receptor.
Andrade SA; Batalha-Carvalho JV; Curi R; Wen FH; Covas DT; Chudzinski-Tavassi AM; Moro AM
Front Immunol; 2022; 13():871874. PubMed ID: 35898497
[TBL] [Abstract][Full Text] [Related]
6. SARS-CoV-2 Variants Show Different Host Cell Proteome Profiles With Delayed Immune Response Activation in Omicron-Infected Cells.
Metzler M; Tharyan RG; Klann K; Grikscheit K; Bojkova D; Cinatl J; Tascher G; Ciesek S; Münch C
Mol Cell Proteomics; 2023 May; 22(5):100537. PubMed ID: 37001587
[TBL] [Abstract][Full Text] [Related]
7. Characterization of the cellular lipid composition during SARS-CoV-2 infection.
Abdel-Megied AM; Monreal IA; Zhao L; Apffel A; Aguilar HC; Jones JW
Anal Bioanal Chem; 2023 Sep; 415(22):5269-5279. PubMed ID: 37438564
[TBL] [Abstract][Full Text] [Related]
8. SARS-CoV2 variant-specific replicating RNA vaccines protect from disease following challenge with heterologous variants of concern.
Hawman DW; Meade-White K; Archer J; Leventhal SS; Wilson D; Shaia C; Randall S; Khandhar AP; Krieger K; Hsiang TY; Gale M; Berglund P; Fuller DH; Feldmann H; Erasmus JH
Elife; 2022 Feb; 11():. PubMed ID: 35191378
[TBL] [Abstract][Full Text] [Related]
9. Key mutations on spike protein altering ACE2 receptor utilization and potentially expanding host range of emerging SARS-CoV-2 variants.
Wang Q; Ye SB; Zhou ZJ; Li JY; Lv JZ; Hu B; Yuan S; Qiu Y; Ge XY
J Med Virol; 2023 Jan; 95(1):e28116. PubMed ID: 36056469
[TBL] [Abstract][Full Text] [Related]
10. Neurological aspects of SARS-CoV-2 infection: lipoproteins and exosomes as Trojan horses.
Lam SM; Huang X; Shui G
Trends Endocrinol Metab; 2022 Aug; 33(8):554-568. PubMed ID: 35613979
[TBL] [Abstract][Full Text] [Related]
11. Anti-SARS-CoV-2 activity of targeted kinase inhibitors: Repurposing clinically available drugs for COVID-19 therapy.
Boytz R; Słabicki M; Ramaswamy S; Patten JJ; Zou C; Meng C; Hurst BL; Wang J; Nowak RP; Yang PL; Sattler M; Stone RM; Griffin JD; Gray NS; Gummuluru S; Davey RA; Weisberg E
J Med Virol; 2023 Jan; 95(1):e28157. PubMed ID: 36117402
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic potential of green tea catechin, (-)-epigallocatechin-3-
Dinda B; Dinda S; Dinda M
Phytomed Plus; 2023 Feb; 3(1):100402. PubMed ID: 36597465
[TBL] [Abstract][Full Text] [Related]
13. Host Response to SARS-CoV2 and Emerging Variants in Pre-Existing Liver and Gastrointestinal Diseases.
Nayak B; Lal G; Kumar S; Das CJ; Saraya A; Shalimar
Front Cell Infect Microbiol; 2021; 11():753249. PubMed ID: 34760721
[TBL] [Abstract][Full Text] [Related]
14. Novel siRNA therapeutics demonstrate multi-variant efficacy against SARS-CoV-2.
Bowden-Reid E; Ledger S; Zhang Y; Di Giallonardo F; Aggarwal A; Stella AO; Akerman A; Milogiannakis V; Walker G; Rawlinson W; Turville S; Kelleher AD; Ahlenstiel C
Antiviral Res; 2023 Sep; 217():105677. PubMed ID: 37478918
[TBL] [Abstract][Full Text] [Related]
15. The global succinylation of SARS-CoV-2-infected host cells reveals drug targets.
Liu Q; Wang H; Zhang H; Sui L; Li L; Xu W; Du S; Hao P; Jiang Y; Chen J; Qu X; Tian M; Zhao Y; Guo X; Wang X; Song W; Song G; Wei Z; Hou Z; Wang G; Sun M; Li X; Lu H; Zhuang X; Jin N; Zhao Y; Li C; Liao M
Proc Natl Acad Sci U S A; 2022 Jul; 119(30):e2123065119. PubMed ID: 35858407
[TBL] [Abstract][Full Text] [Related]
16. Targeting the Fusion Process of SARS-CoV-2 Infection by Small Molecule Inhibitors.
Park SB; Irvin P; Hu Z; Khan M; Hu X; Zeng Q; Chen C; Xu M; Leek M; Zang R; Case JB; Zheng W; Ding S; Liang TJ
mBio; 2022 Feb; 13(1):e0323821. PubMed ID: 35012356
[TBL] [Abstract][Full Text] [Related]
17. Identification of druggable host dependency factors shared by multiple SARS-CoV-2 variants of concern.
Frasson I; Diamante L; Zangrossi M; Carbognin E; Dalla Pietà A; Penna A; Rosato A; Verin R; Torrigiani F; Salata C; Dizanzo MP; Vaccaro L; Cacchiarelli D; Richter SN; Montagner M; Martello G
J Mol Cell Biol; 2024 Feb; ():. PubMed ID: 38305139
[TBL] [Abstract][Full Text] [Related]
18. Genetic Surveillance of SARS-CoV-2 M
Lee JT; Yang Q; Gribenko A; Perrin BS; Zhu Y; Cardin R; Liberator PA; Anderson AS; Hao L
mBio; 2022 Aug; 13(4):e0086922. PubMed ID: 35862764
[TBL] [Abstract][Full Text] [Related]
19. Recognition of Variants of Concern by Antibodies and T Cells Induced by a SARS-CoV-2 Inactivated Vaccine.
Melo-González F; Soto JA; González LA; Fernández J; Duarte LF; Schultz BM; Gálvez NMS; Pacheco GA; Ríos M; Vázquez Y; Rivera-Pérez D; Moreno-Tapia D; Iturriaga C; Vallejos OP; Berríos-Rojas RV; Hoppe-Elsholz G; Urzúa M; Bruneau N; Fasce RA; Mora J; Grifoni A; Sette A; Weiskopf D; Zeng G; Meng W; González-Aramundiz JV; González PA; Abarca K; Ramírez E; Kalergis AM; Bueno SM
Front Immunol; 2021; 12():747830. PubMed ID: 34858404
[TBL] [Abstract][Full Text] [Related]
20. The impact of spike mutated variants of SARS-CoV2 [Alpha, Beta, Gamma, Delta, and Lambda] on the efficacy of subunit recombinant vaccines.
Mohammadi M; Shayestehpour M; Mirzaei H
Braz J Infect Dis; 2021; 25(4):101606. PubMed ID: 34428473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
